Navigation Links
SIRO Clinpharm Strengthens its Clinical Trials Supplies Service Offering in India
Date:10/15/2009

MUMBAI, India, Oct. 15 /PRNewswire/ -- SIRO Clinpharm, a global Contract Research Organization (CRO) with its base in India, US, Europe and Israel, today announced expansion of its Clinical Trials Supplies facility in Mumbai, India. This expansion has been fueled by a demand by pharmaceutical and biotech companies for storage and distribution of clinical trial supplies. The facility is strategically located in Mumbai.

"We opened our clinical trials supplies warehouse in 2003 with a modest area of 1800 square feet," said Jayanti Vaidyanath, Vice President, Administration, Legal & Clinical Trials Supplies Management. "Those days we were one of the few CROs based out of India to have such a facility. Now, with the expanded facility, we have a bigger area of 6200 square feet with room for further expansion. We currently have two walk-in cold rooms at 2-8 degree storage, ambient storage at 15-25 degrees and storages for temperature ranges between -20 and -70 degrees. We have also significantly strengthened our inventory management process using the recently implemented Oracle Siebel CTMS tool," she added.

"The facility expansion will enable us to handle many more orders thus increasing our ability to serve a wider client base," said Dr. Ajit Nair, President, India Operations. "Very recently, we have partnered with a global leader in logistics to support them in Clinical Trials Supplies management in India. This broadens our scope by making us a part of their global storage and distribution network and increases the platform to work on for our international pharma and biotech clients," he added.

About SIRO: SIRO Clinpharm Private Limited (SIRO) is among one of the leading global Clinical Research Organizations (CROs), offering full scope services, conducting clinical trials in the Pharmaceutical, Biotechnology and Medical Devices sectors in compliance with International Standards. SIRO is one of the first CROs founded in India, which caters to the needs of pharmaceutical companies across the world. The company has offices in India, USA, Israel and in Europe in Germany, Romania, Estonia, Czech Republic and Greece. For more information, please visit our website - www.siroclinpharm.com.

SOURCE SIRO Clinpharm


'/>"/>
SOURCE SIRO Clinpharm
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SIRO ClinPharm and Advanced Clinical Trial Solutions Ink Strategic Alliance
2. Medpace Strengthens Presence in Central Europe
3. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
4. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
5. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
6. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
7. Anavex strengthens Board of Directors
8. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
9. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
10. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
11. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec 5, 2016 Research and ... "Biomarkers - Technologies, Markets and Companies" to their offering. ... , , ... their discovery using various -omics technologies such as proteomics and metabolomics. ... new tests are also based on biomarker. Currently the ...
(Date:12/5/2016)... 2016 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the ... and Safety Monitoring Board (DSMB) for the Company,s ... (CVD) patients has completed a second planned safety ... as planned without any modifications. The DSMB reviewed ... or efficacy concerns were identified. The DSMB will ...
(Date:12/4/2016)... ... December 02, 2016 , ... A proposed five-year extension ... federally funded research and development is welcome news for the photonics community, say ... , As part of the National Defense Authorization Act (NDAA) compromise agreement finalized ...
(Date:12/2/2016)... 2016 More than $4.3 million was raised last ... DHMD ). The gala was held at the American Museum ... and honored Alan Alda and ... and medicine and the public understanding of science. Since the ... event has raised $40 million for the Laboratory,s research and ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
(Date:6/27/2016)... 27, 2016 Research and Markets has announced ... report to their offering. ... to grow at a CAGR of 12.28% during the ... on an in-depth market analysis with inputs from industry experts. The ... coming years. The report also includes a discussion of the key ...
(Date:6/21/2016)... British Columbia , June 21, 2016 /PRNewswire/ ... appointed to the new role of principal product ... been named the director of customer development. Both ... NuData,s chief technical officer. The moves reflect NuData,s ... teams in response to high customer demand and ...
Breaking Biology News(10 mins):